Bacterial selectivity and plausible mode of antibacterial action of designed Pro-rich short model antimicrobial peptides

✍ Scribed by Ka Hyon Park; Yoonkyung Park; II-Seon Park; Kyung-Soo Hahm; Song Yub Shin

• Publisher: John Wiley and Sons
• Year: 2008
• Tongue: English
• Weight: 220 KB
• Volume: 14
• Category: Article
• ISSN: 1075-2617
• DOI: 10.1002/psc.1019

✦ Synopsis

Abstract

To develop novel Pro‐rich model AMPs with shorter length and higher bacterial selectivity/therapeutic index (TI) than natural AMP, indolicidin, we synthesized a series of undodecapeptides derived from the sequence XXPXXPWXPXX‐NH~2~ (X indicates Leu or Lys) with different ratios of Lys and Leu residues. Several Pro‐rich model peptides (K~7~WP~3~, K~6~WL~1~P~3~, K~5~WL~2~P~3~‐1, K~5~WL~2~P~3~‐2, and K~4~WL~3~P~3~) had approximate 8‐ to 11‐fold higher bacterial selectivity/TI compared to indolicidin. These peptides selectively bind to negatively charged liposomes (EYPG/EYPG; 7:3, w/w) mimicking bacterial membranes. Their high selectivity to negatively charged phospholipids corresponds well with their high bacterial selectivity. Indolicidin showed almost complete depolarization of the cytoplasmic membrane of Staphylococcus aureus and dye‐leakage from negatively charged liposomes at 10 µM, whereas all of Pro‐rich model peptides had very little activity in these assays even at 80 µM, as observed in buforin 2. These results suggest that the ultimate target of our designed Pro‐rich model peptides is probably the intracellular components (e.g. protein, DNA or RNA) rather than the cytoplasmic membranes. Collectively, our designed Pro‐rich short model peptides appear to be excellent candidates for future development as a novel antimicrobial agent. Copyright © 2008 European Peptide Society and John Wiley & Sons, Ltd.